Work

Immunotherapy: IMAGINE STUDY: INTERIM TRANSLATIONAL OUTCOMES OF VARNIMCABTAGENE AUTOLEUCEL (IMN-003A) FROM FIRST-IN-INDIA PHASE 2 TRIAL FOR ANTI CD19-CAR-T CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY B CELL MALIGNANCIES

Year: 2023
Type: article
Source: Cytotherapy
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4376111032
FWCI: 0.122
Cites:
Cited by: 1
Related to: 10